Andrew H. Beck
M.D., Ph.D.
CEO and Co-founder
👥Biography 个人简介
Andrew Beck is a pathologist-scientist who founded PathAI to develop AI-powered pathology diagnostics. His research at Harvard demonstrated that machine learning could match or exceed pathologist accuracy for certain diagnostic tasks. Beck's company develops AI tools for drug development and clinical diagnostics, partnering with major pharmaceutical companies to accelerate precision medicine.
Andrew Beck是一位病理学家-科学家,创立了PathAI来开发AI驱动的病理诊断。他在哈佛的研究表明,机器学习可以在某些诊断任务上达到或超过病理学家的准确性。Beck的公司开发用于药物开发和临床诊断的AI工具,与主要制药公司合作加速精准医学。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
PathAI Platform
Built commercial AI pathology platform used by major pharmaceutical companies.
Clinical Validation
Conducted rigorous clinical validation studies of AI pathology systems.
Representative Works 代表性著作
Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival
Science Translational Medicine (2011)
Demonstrated prognostic value of computational pathology features.
📄Data Sources 数据来源
Last updated: 2026-03-05 | All information from publicly available academic sources
Related Experts 相关专家
Faisal Mahmood
Harvard Medical School / Brigham and Women's Hospital
Anne E. Carpenter
Broad Institute
Thomas J. Fuchs
Mount Sinai / Paige.AI
Kun-Hsing Yu
Harvard Medical School
关注 Andrew H. Beck 的研究动态
Follow Andrew H. Beck's research updates
留下邮箱,当我们发布与 Andrew H. Beck(PathAI)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment